Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

Takotsubo Syndrome: Does Gender Impact Prognosis?

Takotsubo Syndrome (STT) is characterized by acute cardiac failure which can be reversed in many occasions, but is associated with morbidity and mortality at short and long term. 

Síndrome de Tokotsubo ¿El género tiene influencia en su pronóstico?

It is most frequent among women, especially after menopause. However, gender differences have not been looked into when analyzing the evolution of this cardiomyopathy. 

This was an analysis of the GEIST Registry including 2492 patients with STT. 286 were men (11%).

Men were younger (69 vs. 71, P=0.005), presented more smoking, diabetes, pulmonary disease, and cancer. In addition, they presented more dyspnea and less precordial pain vs. women. 

STT triggering episodes were more physical in men and more emotional in women. 

There were no differences in ECG, but there was in ejection fraction, which was lower in men (38% vs. 40% P=0.001).

Read also: Results of Zotarolimus-Eluting Stents vs Biolimus-Eluting Polymer-Free Stents After 2 Years. Are They Safe in Patients at High Risk for Bleeding?

Men presented more cardiogenic shock (19% vs. 8% P<0.001), inhospital mortality (7% vs. 2% P<0.001) and longer hospital stay.

After propensity score matching 207 pair of patients were left in each group: men had more cardiogenic shock and higher mortality (16% vs 6%, P=0.002 and 8% vs 3%; P=0.003 respectively). 

At long term followup, mortality was 4.3% patient/ years, and was higher in men (10% vs. 3.8% patient /year in the complete series, and 11.5% vs 6.1% patient/year in the matched cohort, respectively). At 60-day followup, mortality was higher in men, but this was not the case in the matched cohort.

Read also: PCI on Native Arteries or Saphenous Vein Grafts: Which Has Better Prognosis?

Multivariable analysis showed that male sex was a predictor of inhospital mortality and mortality at followup. 

Conclusion

Takotsubo syndrome in men involves high risk, and therefore requires more strict control in hospital and after discharge, at long term. 

Dr. Carlos Fava - Consejo Editorial SOLACI

Dr. Carlos Fava.
Member of the Editorial Board of SOLACI.org.

Original Title: Gender Differences in Takotsubo Syndrome.

Reference: Luca Arcari, J Am Coll Cardiol 2022;79:2085–2093.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

EuroPCR 2026 | TAVI and Coronary Artery Disease: FFR-Guided PCI Showed Better Outcomes Than an Angiography-Guided Strategy

In patients undergoing TAVI, the concomitant presence of coronary artery disease continues to generate debate: whether coronary lesions should be treated before, during, or...

EuroPCR 2026 | Evolocumab Reduces Cardiovascular Events in Patients With Prior PCI Without Previous Myocardial Infarction: VESALIUS-CV Results

This presentation, delivered by Dr. Brian A. Bergmark and colleagues at EuroPCR 2026, detailed the results of the VESALIUS-CV trial, focusing specifically on the...

EuroPCR 2026 | Is It Safe to Stop Aspirin After One Month in MI Patients Undergoing PCI? TARGET-FIRST Analysis

This is a summary of the post-hoc analysis of the TARGET-FIRST study, presented by Dr. Giuseppe Tarantini at EuroPCR 2026, evaluating early aspirin discontinuation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

EuroPCR 2026 | MELA Registry: Myval Showed Lower Aortic Regurgitation Rates in Patients With Large Aortic Annuli

This presentation, delivered by Dr. Salvatore Giordano at EuroPCR 2026, detailed the results of the MELA Registry, a multicenter study comparing the performance of...

EuroPCR 2026 | LANDMARK Trial: Two-Year Results Showed Comparable Efficacy Between Myval and Contemporary TAVI Valves

The LANDMARK trial presentation, delivered by Prof. Patrick W. Serruys at EuroPCR 2026, detailed the two-year clinical outcomes of contemporary transcatheter aortic valve implantation...

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...